Spokane

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• COPD1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 32 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Tesaro, Inc.2 trials
• GlaxoSmithKline1 trial

Running trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  NCT07780656· Phase 3· GlaxoSmithKline· Source

  Contact: Sarah Smiley (principal investigator)

• Active, not recruiting

  A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

  NCT02655016· Phase 3· Tesaro, Inc.· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting